SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-20-000504
Filing Date
2020-04-15
Accepted
2020-04-15 17:24:15
Documents
13
Period of Report
2020-04-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 30407
2 PRESS RELEASE ex99-1.htm EX-99.1 20320
  Complete submission text file 0000950157-20-000504.txt   197406

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myl-20200415.xsd EX-101.SCH 4183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myl-20200415_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myl-20200415_pre.xml EX-101.PRE 16209
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4087
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 20794474
SIC: 2834 Pharmaceutical Preparations